Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Abbott denied patent for liponavir/ritonavir HIV drug combo in India
India Rejects Patent Application for Abbott’s Kaletra
Abbott’s HIV drug patent plea rejected for lack of novelty
Abbott Laboratories HIV Drug Rejected
India Rejects Abbott patent of Kaletra AIDS drug
India rejects Abbott’s patent application for Kaletra
India Rejects Abbott’s Patent Application for Lifesaving HIV Drug
India Rejects Abbot Lab’s Patent Application for HIV Drug
India Rejects Abbott Lab’s Patent Application for HIV Drug
Global HIV Patients Get India Boost vs Abbott